3-15451674-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1PP2
The NM_005677.4(COLQ):c.1338C>G(p.Ile446Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. I446I) has been classified as Likely benign.
Frequency
Consequence
NM_005677.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005677.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COLQ | NM_005677.4 | MANE Select | c.1338C>G | p.Ile446Met | missense | Exon 17 of 17 | NP_005668.2 | ||
| COLQ | NM_080538.2 | c.1308C>G | p.Ile436Met | missense | Exon 17 of 17 | NP_536799.1 | |||
| COLQ | NM_080539.4 | c.1236C>G | p.Ile412Met | missense | Exon 16 of 16 | NP_536800.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COLQ | ENST00000383788.10 | TSL:1 MANE Select | c.1338C>G | p.Ile446Met | missense | Exon 17 of 17 | ENSP00000373298.3 | ||
| COLQ | ENST00000603808.5 | TSL:1 | c.1341C>G | p.Ile447Met | missense | Exon 17 of 17 | ENSP00000474271.1 | ||
| ENSG00000293553 | ENST00000629729.3 | TSL:5 | n.*62C>G | non_coding_transcript_exon | Exon 3 of 6 | ENSP00000518887.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152188Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000318 AC: 8AN: 251324 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461848Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74346 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Uncertain:2
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 446 of the COLQ protein (p.Ile446Met). This variant is present in population databases (rs73818504, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with COLQ-related conditions. ClinVar contains an entry for this variant (Variation ID: 567550). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not provided Uncertain:2
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Inborn genetic diseases Uncertain:1
The c.1338C>G (p.I446M) alteration is located in exon 17 (coding exon 17) of the COLQ gene. This alteration results from a C to G substitution at nucleotide position 1338, causing the isoleucine (I) at amino acid position 446 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
COLQ-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at